Cardio Diagnostics Expands HeartRisk Platform

Cardio Diagnostics Leverages AI for Nationwide Expansion of HeartRisk Platform

Chicago, February 15, 2024 – In a significant push to reinvigorate the cardiovascular health sector, Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), is rolling out its trailblazing HeartRisk™ platform across the United States, impacting traditional and unique healthcare sectors like correctional facilities. This expansion is a testament to the company's innovative approach in integrating AI-driven precision cardiovascular medicine to enhance disease management and healthcare delivery.